Dermapharm Holding SE
General ticker "DMPHF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.2B (TTM average)
Dermapharm Holding SE does not follow the US Stock Market performance with the rate: -16.4%.
Estimated limits based on current volatility of 0.0%: low 39.56$, high 39.56$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-06-30, amount 1.05$ (Y2.65%)
Short-term DMPHF quotes
Long-term DMPHF plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | €1,180.77MM |
| Operating Expenses | €963.83MM |
| Operating Income | €216.93MM |
| Non-Operating Income | €-44.93MM |
| Interest Expense | €58.41MM |
| R&D Expense | €11.54MM |
| Income(Loss) | €172.00MM |
| Taxes | €60.27MM |
| Profit(Loss)* | €113.79MM |
| Stockholders Equity | €604.42MM |
| Inventory | €339.86MM |
| Assets | €2,080.02MM |
| Operating Cash Flow | €201.38MM |
| Capital expenditure | €38.24MM |
| Investing Cash Flow | €-29.61MM |
| Financing Cash Flow | €-209.17MM |
| Earnings Per Share** | €2.11 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.